Dyspareunia Sexual Dysfunction, Physiological
Conditions
Interventions
This is a randomized, parallel, single-blind, multicenter, two arm clinical trial. In the control group, a U shaped perineal massage will be performed with stretching of the deep pelvic floor muscles,
Sponsors
Universidade Federal do Delta do Parnaíba - UFDPar
Universidade Federal do Delta do Parnaíba - UFDPar
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Female volunteers experiencing pain during penetrative sexual activity (dyspareunia); aged between 18 and 40 years; able to understand and respond appropriately to the assessment instruments; have up-to-date gynecological examinations; be available to participate in all stages of the study; and sign the Informed Consent Form
Exclusion criteria
Exclusion criteria: Pregnant volunteers; volunteers in the postpartum period; diagnosed with serious neurological, rheumatological, oncological, or gynecological diseases; history of recent pelvic surgeries; presence of active genital infections; volunteers who have undergone pelvic physiotherapy treatment for sexual pain
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that pain during penetrative sexual activity will decrease, as measured by a Visual Analogue Scale (VAS) ranging from 0 to 10, where 0 represents no pain and 10 the worst imaginable pain. Data on this outcome will be collected at the beginning of the study (baseline) and at the end of the interventions, as well as at the beginning and end of each session, allowing for analysis of the immediate response to the intervention. Additionally, pain will be reassessed at follow-up periods of 1, 3, 6, and 12 months to verify the maintenance of the effects over time | — |
Secondary
| Measure | Time frame |
|---|---|
| An improvement in the severity of dyspareunia is expected, as assessed using the Deep and Superficial Dyspareunia Questionnaire (DSDQ). This instrument will be applied at the beginning of the research and after the interventions, as well as during the 1, 3, 6, and 12-month follow-up periods;An improvement in female sexual function is expected, as assessed by the Female Sexual Function Index (FSFI). This instrument will be applied at the beginning of the research and after the interventions, as well as during the 1, 3, 6, and 12-month follow-up periods | — |
Countries
AR, BR, CL, CO, MX
Contacts
Public ContactMatheaus da Costa
Universidade Federal do Delta do Parnaíba - UFDPar
Outcome results
None listed